James B. Renacci bought Core Laboratories NV (NYSE: CLB)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 20 trades in Core Laboratories NV (CLB) since 2014, 9 purchases and 11 sales, worth an estimated $608K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James B. Renacci bought $1,000 - $15,000 of Core Laboratories NV (NYSE: CLB) on December 15, 2017. Since that trade, CLB is down -89.12% against the S&P 500 up +210.98%, an outperformance of -300.10%.
Across these filings, James B. Renacci has been a net seller of CLB (a buy-to-sell ratio of 0.82). The most recent disclosed CLB transaction shown was dated December 10, 2018. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's CLB trades vs the price
CLB is down -89.12% since James B. Renacci bought on December 15, 2017, versus +210.98% for the S&P 500.
Performance since this trade
All James B. Renacci CLB trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & CLB trading FAQ
Is it legal for James B. Renacci to trade Core Laboratories NV (CLB) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Core Laboratories NV (CLB), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci buy CLB?
James B. Renacci disclosed a purchase of $1,000 - $15,000 of Core Laboratories NV (CLB) on December 15, 2017, according to public STOCK Act filings.
How has CLB performed since James B. Renacci's trade?
Since James B. Renacci bought CLB on December 15, 2017, the stock is down -89.12%, versus +210.98% for the S&P 500 over the same period, an outperformance of -300.10%.
How many times has James B. Renacci traded CLB?
James B. Renacci has disclosed 20 CLB trades since 2014 (9 purchases and 11 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CLB trades?
Quantellect tracks every disclosed congressional trade in Core Laboratories NV (CLB) on the Core Laboratories NV congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's CLB tradesAll congressional filings for Core Laboratories NVJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.